Pharmaceutical Products

In the face of continually escalating healthcare products’ prices from pharmaceutical companies, affordable access to medicines is a public health concern. Some reports highlighted an annual growth rate of 6% on medication spend, which has outpaced general health spending. In fact, in some of the Southeast Asian countries, the percentage increases to 9%. On a global scale, the World Health Organization estimates that a staggering 100 million people each year are pushed below the poverty line due to rising health care costs. Safe, effective, and high-quality products are our goals, and it is vital in our health care system. We work together with top pharmaceutical companies around the world and strive to offer an alternative way of providing more affordable and variables products to a larger number of people. Our commitment will never end.

Moreover, our pharmaceutical products are held to high approval and manufacturing standards. Regulatory agency’s scientific review and assessment for registration of products assured our consumers of safety and quality issues. After product approval, we continue to monitor for any adverse events.

We’re engaged and encourage to expand our Pharmaceutical Products pipeline from the development of generic drugs to complex drugs or targeted treatments and Medication. We will continue to do our best to facilitate a stable, competitive market to increase medicines’ access.